Zavala-Vargas, D. I. | Search bioRxiv

bioRxiv2022

Molecular Transport of the Zika Virus by the Human Cytoplasmic Dynein-1

Zika virus (ZIKV) infection is a major public health threat, making the study of its biology a matter of great importance. By analyzing the viral-host protein interactions and proposing them as new drug targets, we would diminish the emergence of new resistant strains. In this work, we have shown that human cytoplasmic dynein-1 (Dyn) interacts with the ZIKV. We additionally demonstrate that the envelope protein of the ZIKV and the dimerization domain of the heavy chain of Dyn binds directly without dynactin or cargo adaptor. In addition, we have analyzed this interaction in Vero cells, where we are proposing that the interaction ZIKV-Dyn is finely tuned within the replication cycle. Altogether, our data suggest a new step in the previously described replication cycle of the ZIKV, introducing a suitable molecular target to modulate infection by ZIKV.

biochemistry↗

bioRxiv2021

ADAM17 inhibition prevents neutrophilia and lung injury in a mouse model of Covid-19

Severe coronavirus disease 2019 (Covid-19) is characterized by lung injury, cytokine storm and increased neutrophil-to-lymphocyte ratio (NLR). Current therapies focus on reducing viral replication and inflammatory responses, but no specific treatment exists to prevent the development of severe Covid-19 in infected individuals. Angiotensin-converting enzyme-2 ACE-2) is the receptor for SARS-CoV-2, the virus causing Covid-19, but it is also critical for maintaining the correct functionality of lung epithelium and endothelium. Coronaviruses induce activation of a disintegrin and metalloprotease 17 (ADAM17) and shedding of ACE-2 from the cell surface resulting in exacerbated inflammatory responses. Thus, we hypothesized that ADAM17 inhibition ameliorates Covid-19-related lung inflammation. We employed a pre-clinical mouse model using intra-tracheal instillation of a combination of polyinosinic:polycytidylic acid (poly-I:C) and the receptor-binding domain of the SARS-CoV-2 spike protein (RBD-S) to mimic lung damage associated with Covid-19. Histological analysis of inflamed mice confirmed the expected signs of lung injury including edema, fibrosis, vascular congestion and leukocyte infiltration. Moreover, inflamed mice also showed an increased NLR as observed in critically ill Covid-19 patients. Administration of the ADAM17 inhibitors apratastat and TMI-1 significantly improved lung histology and prevented leukocyte infiltration. Reduced leukocyte recruitment could be explained by reduced production of pro-inflammatory cytokines and lower levels of the endothelial adhesion molecules ICAM-1 and VCAM-1. Additionally, the NLR was significantly reduced by ADAM17 inhibition. Thus, we propose inhibition of ADAM17 as a novel promising treatment strategy in SARS-CoV-2-infected individuals to prevent the progression towards severe Covid-19.

pathology↗